SoftOx Solutions AS (OSL:SOFTX)
Norway · Delayed Price · Currency is NOK 0.1248
+0.0068 (5.76%)
At close: Sep 18, 2026
SoftOx Solutions AS Revenue
SoftOx Solutions AS had revenue of 3.90M NOK in the quarter ending March 31, 2026, with 21.33% growth. This brings the company's revenue in the last twelve months to 16.27M, up 74.65% year-over-year. In the year 2025, SoftOx Solutions AS had annual revenue of 15.58M with 96.92% growth.
Revenue (ttm)
16.27M
Revenue Growth
+74.65%
P/S Ratio
19.96
Revenue / Employee
8.14M
Employees
2
Market Cap
324.70M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.58M | 7.67M | 96.92% |
| Dec 31, 2024 | 7.91M | 934.01K | 13.38% |
| Dec 31, 2023 | 6.98M | -133.61K | -1.88% |
| Dec 31, 2022 | 7.11M | -787.80K | -9.97% |
| Dec 31, 2021 | 7.90M | -1.94M | -19.69% |
| Dec 31, 2020 | 9.84M | 5.74M | 140.04% |
| Dec 31, 2019 | 4.10M | -224.11K | -5.18% |
| Dec 31, 2018 | 4.32M | 4.32M | 432,213.60% |
| Dec 31, 2017 | 1.00K | -100.00K | -99.01% |
| Dec 31, 2016 | 101.00K | -224.00K | -68.92% |
| Dec 31, 2014 | 325.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 133.41M |
| Arctic Bioscience AS | 48.96M |
| Oncoinvent ASA | 24.31M |
| Aqua Bio Technology ASA | 5.67M |
| Nykode Therapeutics AS | 4.60M |
| Thor Medical ASA | 1.64M |
| Lytix Biopharma ASA | 377.00K |
| Circio Holding ASA | 123.00K |
SoftOx Solutions AS News
- 2 months ago - SoftOx Solutions AS Quarterly report: Q1 2026 - Filings
- 5 months ago - SoftOx Solutions AS Quarterly report: Q4 2025 - Filings
- 5 months ago - SoftOx Solutions AS Annual report: Q4 2025 - Filings
- 9 months ago - SoftOx Solutions AS Quarterly report: Q3 2025 - Filings